Novo Nordisk A/S - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novo Nordisk A/S (Novo Nordisk or 'the company') is a pharmaceutical company. It produces and develops biological medications with a primary focus on developing therapies for diabetes and other severe chronic ailments like hemophilia, abnormalities of human growth hormone (HGH), and obesity. The company’s portfolio includes pre-filled delivery systems for HGH, and insulin; glucagon hypokit; needles; cartridge; vials; insulin; estradiol for hormone replacement; recombinant drugs for hemophilia; glucagon; and oral antidiabetic agents. Its major products across different therapy areas include Tresiba, NovoRapid, Ryzodeg, Fiasp, Levemir, Insulatard, NovoPen, Saxenda, NordiPen, Activelle, Vagifem, and others. Novo Nordisk has operations across North America, Asia, Europe, the Middle East and Africa. The company is headquartered in Bagsvaerd, Denmark.Scope
- Detailed information on Novo Nordisk A/S required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novo Nordisk A/S in the form of a SWOT analysis
- An in-depth view of the business model of Novo Nordisk A/S including a breakdown and examination of key business segments
- Intelligence on Novo Nordisk A/S's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novo Nordisk A/S, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Novo Nordisk A/S and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novo Nordisk A/S as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novo Nordisk A/S's business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Novo Nordisk A/S: Company Overview
- Novo Nordisk A/S: Overview and Key Facts
- Novo Nordisk A/S: Overview
- Novo Nordisk A/S: Key Facts
- Novo Nordisk A/S: Key Employees
- Novo Nordisk A/S: Key Employee Biographies
- Novo Nordisk A/S: Major Products and Services
- Novo Nordisk A/S: Management Statement
- Novo Nordisk A/S: Locations and Subsidiaries
- Novo Nordisk A/S: Key Competitors
- Novo Nordisk A/S: Company Analysis
- Novo Nordisk A/S: Business Description
- Novo Nordisk A/S: SWOT Analysis
- Novo Nordisk A/S: SWOT Overview
- Novo Nordisk A/S: Strengths
- Novo Nordisk A/S: Weaknesses
- Novo Nordisk A/S: Opportunities
- Novo Nordisk A/S: Threats
- Novo Nordisk A/S: Corporate Financial Deals Activity
- Novo Nordisk A/S: Financial Deals Overview
- Novo Nordisk A/S: Targets and Partners
- Novo Nordisk A/S: Top Deals 2020 - 2024YTD*
- Novo Nordisk A/S: Advisors
- Novo Nordisk A/S: Top Legal Advisors
- Novo Nordisk A/S: Top Financial Advisors
- Novo Nordisk A/S: Mergers and Acquisitions
- Novo Nordisk A/S: Corporate Venturing
- Novo Nordisk A/S: Capital Raising
- Novo Nordisk A/S: Partnership
- Novo Nordisk A/S: Recent Developments
- Novo Nordisk A/S: News and Events Summary
- Novo Nordisk A/S: Business Expansion
- Novo Nordisk A/S: Contracts
- Novo Nordisk A/S: Financial Deals
- Novo Nordisk A/S: Financial Performance
- Novo Nordisk A/S: Regulatory and Legal Events
- Novo Nordisk A/S: Research & Development
- Novo Nordisk A/S: Strategy and Operations
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: Novo Nordisk A/S: Key Facts
- Table 2: Novo Nordisk A/S: Key Employees
- Table 3: Novo Nordisk A/S: Locations and Subsidiaries
- Table 4: Novo Nordisk A/S: Key Competitors
- Table 5: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Novo Nordisk A/S: M&A Activity by Geography (TTM*)
- Table 7: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 8: Novo Nordisk A/S: M&A Average Deal Size - Value (US$m)
- Table 9: Novo Nordisk A/S: Targets and Partners
- Table 10: Novo Nordisk A/S: Top Deals 2020 - 2024YTD*
- Table 11: Novo Nordisk A/S: Legal Advisor Ranking by Value (US$m)
- Table 12: Novo Nordisk A/S: Financial Advisor Ranking by Value (US$m)
- Table 13: Novo Nordisk A/S: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 14: Novo Nordisk A/S: M&A Activity by Geography (2020 - YTD*2024)
- Table 15: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Table 16: Novo Nordisk A/S: Corporate Venturing by Geography (2020 - YTD*2024)
- Table 17: Novo Nordisk A/S: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 18: Novo Nordisk A/S: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 19: Novo Nordisk A/S: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 20: Novo Nordisk A/S: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 21: Novo Nordisk A/S: News and Events Summary
- Table 22: Novo Nordisk A/S: Business Expansion
- Table 23: Novo Nordisk A/S: Contracts
- Table 24: Novo Nordisk A/S: Financial Deals
- Table 25: Novo Nordisk A/S: Financial Performance
- Table 26: Novo Nordisk A/S: Regulatory and Legal Events
- Table 27: Novo Nordisk A/S: Research & Development
- Table 28: Novo Nordisk A/S: Strategy and Operations
- Figure 1: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Novo Nordisk A/S: M&A Activity by Geography (TTM*)
- Figure 3: Novo Nordisk A/S: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 4: Novo Nordisk A/S: M&A Average Deal Size - Value (US$m)
- Figure 5: Novo Nordisk A/S: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 6: Novo Nordisk A/S: M&A Activity by Geography (2020 - YTD*2024)
- Figure 7: Novo Nordisk A/S: Corporate Venturing Volume and Value Trend (2020 - YTD*2024)
- Figure 8: Novo Nordisk A/S: Corporate Venturing by Geography (2020 - YTD*2024)
- Figure 9: Novo Nordisk A/S: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 10: Novo Nordisk A/S: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 11: Novo Nordisk A/S: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 12: Novo Nordisk A/S: Partnership Trend by Deal Type (2020 - YTD*2024)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
